ATTENTION-DEFICIT/HYPERACTIVITY DISORDER (ADHD)

Clinical trials for ATTENTION-DEFICIT/HYPERACTIVITY DISORDER (ADHD) explained in plain language.

Never miss a new study

Get alerted when new ATTENTION-DEFICIT/HYPERACTIVITY DISORDER (ADHD) trials appear

Sign up with your email to follow new studies for ATTENTION-DEFICIT/HYPERACTIVITY DISORDER (ADHD), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 15 Not yet recruiting 6 Not yet finished but already full! 4 Completed 9 Terminated 1

ADHD drug trial for teens halted early – what we know

Symptom relief Terminated

This study tested a new medicine called NRCT-101SR for teenagers aged 13 to 17 with ADHD. The goal was to see if it safely reduces ADHD symptoms compared to a placebo. The trial was stopped early, so results are limited. It involved 95 participants and used standard ADHD rating s…

Matched conditions: ATTENTION-DEFICIT/HYPERACTIVITY DISORDER (ADHD)

Phase: PHASE2, PHASE3 • Sponsor: Neurocentria, Inc. • Aim: Symptom relief

Last updated Jun 27, 2026 08:11 UTC

ATTENTION-DEFICIT/HYPERACTIVITY DISORDER (ADHD)

Get alerted when new ATTENTION-DEFICIT/HYPERACTIVITY DISORDER (ADHD) trials appear

ADHD drug trial for teens halted early – what we know